Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2021 | 03-2018 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -900,233 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,752 | N/A | N/A | N/A |
| Other Working Capital | 71,938 | N/A | N/A | N/A |
| Other Operating Activity | 272,405 | 0 | 0 | 0 |
| Operating Cash Flow | $-552,138 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -5,806 | N/A | N/A | N/A |
| Other Investing Activity | -25,896 | 0 | 0 | 0 |
| Investing Cash Flow | $-31,702 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 455,756 | N/A | N/A | N/A |
| Other Financing Activity | 508 | 0 | 0 | 0 |
| Financing Cash Flow | $456,264 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,269,252 | N/A | N/A | N/A |
| End Cash Position | 2,141,676 | N/A | N/A | N/A |
| Net Cash Flow | $-127,576 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -552,138 | N/A | N/A | N/A |
| Capital Expenditure | -5,806 | N/A | N/A | N/A |
| Free Cash Flow | -557,944 | 0 | 0 | 0 |